Assessment and effect of a gap between new-onset epilepsy diagnosis and treatment in the US

OBJECTIVE: To estimate the treatment gap between a new epilepsy diagnosis and antiepileptic drug (AED) initiation in the United States. METHODS: Retrospective claims-based cohort study using Truven Health MarketScan databases (commercial and supplemental Medicare, calendar years 2010–2015; Medicaid,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalilani, Linda, Faught, Edward, Kim, Hyunmi, Burudpakdee, Chakkarin, Seetasith, Arpamas, Laranjo, Scott, Friesen, David, Haeffs, Kathrin, Kiri, Victor, Thurman, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537131/
https://www.ncbi.nlm.nih.gov/pubmed/30971487
http://dx.doi.org/10.1212/WNL.0000000000007448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537131/
https://www.ncbi.nlm.nih.gov/pubmed/30971487
http://dx.doi.org/10.1212/WNL.0000000000007448

Ejemplares similares